GS
LLY icon

GTS Securities’s Eli Lilly LLY Stock Holding History

GTS Securities’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12M Sell
1,764
-1,955
-53% -$2M 0.04% 241
2026
Q1 		$3.42M Sell
3,719
-4,427
-54% -$4.49M 0.12% 112
2025
Q4 		$8.75M Buy
8,146
+3,571
+78% +$3.41M 0.3% 42
2025
Q3 		$3.49M Buy
4,575
+1,319
+41% +$982K 0.13% 122
2025
Q2 		$2.54M Sell
3,256
-5,100
-61% -$3.96M 0.11% 138
2025
Q1 		$6.9M Buy
8,356
+4,217
+102% +$3.51M 0.3% 42
2024
Q4 		$3.2M Sell
4,139
-12,420
-75% -$10.3M 0.16% 104
2024
Q3 		$14.7M Buy
16,559
+1,891
+13% +$1.7M 0.03% 359
2024
Q2 		$13.3M Buy
14,668
+13,585
+1,254% +$10.9M 0.03% 388
2024
Q1 		$843K Sell
1,083
-15,162
-93% -$10.8M ﹤0.01% 2120
2023
Q4 		$9.47M Buy
16,245
+9,526
+142% +$5.56M 0.02% 637
2023
Q3 		$3.61M Buy
+6,719
New +$3.46M 0.01% 1120

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GTS Securities's LLY Position: Q2 2026 in Review

GTS Securities reduced its Eli Lilly (LLY) stake by 53% in Q2 2026, selling an estimated $2M and leaving 1,764 shares worth $2.12M. The position accounts for 0.04% of the portfolio, ranked #241.

GTS Securities first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $14.7M in Q3 2024. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • GTS Securities held 1,764 shares of Eli Lilly worth $2.12M as of Q2 2026.
  • GTS Securities sold 1,955 Eli Lilly shares in Q2 2026, an estimated $2M.
  • Eli Lilly made up 0.04% of GTS Securities's portfolio in Q2 2026, its #241 holding.
  • GTS Securities first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • GTS Securities's Eli Lilly position peaked at $14.7M in Q3 2024.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.